Scientists have discovered genetic mutations in brain tumors that alter brain tumor metabolism. The scientists report that cells with defective... Read More
Advertisements
Understanding glioblastoma at the genetic, molecular level Glioblastoma is the most common and most lethal form of brain tumor in... Read More
Researchers at UT Southwestern Medical Center have developed what they believe to be the first clinical application of a new... Read More
Researchers have created a living 3-D model of a brain tumor and its surrounding blood vessels. In experiments, the scientists... Read More
Using nanoparticles and alternating magnetic fields, University of Georgia scientists have found that head and neck cancerous tumor cells in... Read More
Meningioma, the most common primary brain tumor in the United States, accounts for about 33 percent of all primary brain... Read More
Study is first to show feasibility and efficacy of a new use for autologous stem cell transplant. For the first... Read More
New research from the University of Wisconsin-Madison explains why the incurable brain cancer, glioblastoma multiforme (GBM), is highly resistant to... Read More
Johns Hopkins scientists hope discovery will drive drug treatments. Johns Hopkins researchers say they have discovered one of the most... Read More
Researchers at The University of Nottingham have identified three sets of genetic markers that could potentially pave the way for... Read More
Scientists showed in mice that disabling a gene linked to a common pediatric tumor disorder, neurofibromatosis type 1 (NF1), made stem cells from one part of the brain proliferate rapidly. But the same genetic deficit had no effect on stem cells from another brain region. Read More
Researchers at the Stanford University School of Medicine and Lucile Packard Children’s Hospital have identified several gene mutations responsible for the most common childhood brain tumor, called medulloblastoma, adding evidence to the theory that the diagnosis is a group of genetically distinct cancers with different prognoses. These and accompanying findings are likely to lead to less toxic, better targeted treatment approaches over the next two years, the researchers said. Read More
